Revision history of "AMIODARONE (CORDARONE)"

From CRS EMS Guidelines

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • curprev 22:18, 3 April 2022‎ Cgabryszek talk contribs‎ 2,119 bytes +2,119‎ Created page with "'''Class''' Antiarrhythmic agent '''Pharmacology and Actions''' # Suppresses ventricular ectopy and increases ventricular fibrillation threshold. # Noncompetitive blocker of alpha and beta adrenergic receptors which can cause: ## Negative chronotropic effects ## Negative inotropic effects (the effect on cardiac output by the negative inotropic effect is balanced by a decrease in afterload and increase in coronary blood flow, which in turn improves cardiac performance..." Tag: Visual edit
Retrieved from "https://www.crsguidelines.org/index.php?title=AMIODARONE_(CORDARONE)"